193 related articles for article (PubMed ID: 25085667)
1. Gene therapies for inherited skin disorders.
Abdul-Wahab A; Qasim W; McGrath JA
Semin Cutan Med Surg; 2014 Jun; 33(2):83-90. PubMed ID: 25085667
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy and the skin.
Hengge UR; Bardenheuer W
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):93-100. PubMed ID: 15468151
[TBL] [Abstract][Full Text] [Related]
3. Genetic reversion of inherited skin disorders.
Magnaldo T; Sarasin A
Mutat Res; 2002 Nov; 509(1-2):211-20. PubMed ID: 12427540
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
5. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
[TBL] [Abstract][Full Text] [Related]
6. Advances in gene therapy and their application to skin diseases: A review.
Shinkuma S
J Dermatol Sci; 2021 Jul; 103(1):2-9. PubMed ID: 34049771
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous gene transfer and therapy: the present and the future.
Spirito F; Meneguzzi G; Danos O; Mezzina M
J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
[TBL] [Abstract][Full Text] [Related]
8. Progress and prospects of skin gene therapy: a ten year history.
Hengge UR
Clin Dermatol; 2005; 23(1):107-14. PubMed ID: 15708294
[TBL] [Abstract][Full Text] [Related]
9. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and delivery.
Jayarajan V; Kounatidou E; Qasim W; Di WL
Exp Dermatol; 2021 Jul; 30(7):887-896. PubMed ID: 33657662
[TBL] [Abstract][Full Text] [Related]
11. Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases.
Dallinger G; Puttaraju M; Mitchell LG; Yancey KB; Yee C; Klausegger A; Hintner H; Bauer JW
Exp Dermatol; 2003 Feb; 12(1):37-46. PubMed ID: 12631245
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous gene therapy--an update.
Christensen R; Jensen UB; Jensen TG
Histochem Cell Biol; 2001 Jan; 115(1):73-82. PubMed ID: 11219611
[TBL] [Abstract][Full Text] [Related]
13. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
[TBL] [Abstract][Full Text] [Related]
14. An approach to achieve long-term expression in skin gene therapy.
Therrien JP; Pfützner W; Vogel JC
Toxicol Pathol; 2008 Jan; 36(1):104-11. PubMed ID: 18337228
[TBL] [Abstract][Full Text] [Related]
15. [Epidermal stem cells and ex vivo cutaneous gene therapy: application to xeroderma pigmentosum].
Warrick E; Bergoglio V; Bernerd F; Magnaldo T
J Soc Biol; 2008; 202(1):33-41. PubMed ID: 18460307
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous gene therapy--perspectives of gene transfer in keratinocytes].
Braun-Falco M; Hallek M
Hautarzt; 1998 Jul; 49(7):536-44. PubMed ID: 9715380
[TBL] [Abstract][Full Text] [Related]
17. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
18. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
[TBL] [Abstract][Full Text] [Related]
19. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
20. [Hope for new therapies of severe genetic skin diseases].
Egelrud T; Vahlquist A
Lakartidningen; 2000 Oct; 97(42):4722-6. PubMed ID: 11079322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
